In the Spotlight - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

In the Spotlight
Editors' picks of pharmaceutical science and technology innovations.

Pharmaceutical Technology
Volume 34, Issue 8, pp. 24

Editors' Picks of Pharmaceutical Science & Technology Innovations

Automation is not a new concept for the pharmaceutical industry, but companies have lately taken a closer look at the benefits that it can bring. Equipment that performs tasks repeatably and accurately can boost production efficiency and reduce costs and the amount of wasted materials. Many drugmakers are looking for new ways to apply automation in their facilities, and this month's products suggest various solutions. Testo's monitoring system helps personnel control critical environmental conditions. A new screener from Rotex filters materials efficiently and quietly. Freeslate's software system enables scientists to create and perform quality-assurance tests simply.

Monitoring system safeguards data


Saveris monitoring system Testo www.testo.com
Testo's (Sparta, NJ) Saveris system monitors temperature, humidity, and pressure through wireless or Ethernet probes. The system's external temperature probes provide measurements accurate to within 0.4 F, and its external humidity probe provides measurements accurate to within 1%.

The Saveris system's software provides automatic operation and recordkeeping. Users can program the system to send email or text alarm notifications to several responders automatically. In addition, the software creates daily or weekly graphic reports and automatically saves them to a storage location or mails them to chosen recipients.

The system's base can store 40,000 readings per channel if the computer connection is lost. The probe pooling is timed, and data are sent in short bursts. If external interference prevents pooling or affects the transmission, data are stored internally in each probe until communication is re-established to prevent data loss.

Screener increases efficiency


MEGATEX XD screener Rotex Global www.rotex.com
Rotex Global (Cincinnati) has introduced a smaller version of the MEGATEX XD screener that uses a stacked, multiple-deck design to split and distribute the incoming flow of material evenly to all screen decks. The device's screens are wide, rather than long, which increases its capacity.

The machine produces noise levels lower than those emitted by vibratory screeners. Its easily accessible external drive that allows for high product recoveries at material temperatures of 400 F. The stacked, multideck configuration also allows operators to access individual trays without the need to remove all decks.

Laboratory system facilitates testing


Core Module-3 analytical system Freeslate www.freeslate.com
Freeslate's (Sunnyvale, CA) Core Module-3 (CM3) analytical system is designed to automate laboratory processes. The system includes Freeslate's Lab Execution and Analysis software, which is compatible with third-party instruments and enables scientists to design, execute, analyze, and report on experiments in one environment on their desktops.

The CM3 system's configurable design is based on a standard base platform and various arm and deck elements that dispense materials, mix, control temperature, and perform analytical measurements. Scientists can reconfigure the system for new applications easily, says John Senaldi, the company's CEO.

The unit's balance precisely quantifies powders and liquids and provides feedback to a dispensing algorithm to ensure that the correct amount of material is being dispensed. An imaging module allows scientists to see materials at various points during an experiment, thus providing indications of sample stability. The CM3 system is suitable for large-molecule drug formulation stability testing and small-molecule drug polymorph studies.

New Product Announcements

may be sent to New Products Editor, Pharmaceutical Technology, 485 Route One South, Building F, First Floor, Iselin, NJ 08830, fax 732.596.0005,
.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
24%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
10%
All of the above.
44%
No government involvement in patient treatment or drug development.
10%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: Pharmaceutical Technology,
Click here